Abacavir 600 mg + Lamivudine 300 mg
This dual nucleoside reverse transcriptase inhibitor (NRTI) combination forms a core component of antiretroviral therapy, supporting sustained viral suppression in the management of HIV-1 infection when used according to recommended clinical guidelines.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitors (Abacavir + Lamivudine)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Abacavir 600 mg + Lamivudine 300 mg
This dual nucleoside reverse transcriptase inhibitor (NRTI) combination forms a core component of antiretroviral therapy, supporting sustained viral suppression in the management of HIV-1 infection when used according to recommended clinical guidelines.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitors (Abacavir + Lamivudine)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Abacavir 600 mg + Lamivudine 300 mg
This dual nucleoside reverse transcriptase inhibitor (NRTI) combination forms a core component of antiretroviral therapy, supporting sustained viral suppression in the management of HIV-1 infection when used according to recommended clinical guidelines.
Product Details
Therapeutic Class
Nucleoside Reverse Transcriptase Inhibitors (Abacavir + Lamivudine)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
One tablet once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets